Mineralys Therapeutics Inc. (MLYS) Social Stream
MINERALYS THERAPEUTICS INC (MLYS) Price Targets From Analysts
Use the tables below to see what analysts covering MINERALYS THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-06 | 5 | $45 | $39 | $42 | $8.65 | 385.55% |
| 2023-08-07 | 5 | $45 | $32 | $38.666 | $8.65 | 347.01% |
| 2023-11-07 | 5 | $45 | $32 | $37.666 | $8.65 | 335.45% |
| NA | 2 | $NA | $NA | $NA | $8.65 | NA% |
Over the past 35 weeks, MLYS's average upside potential has been 194.82%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-07 | 2 | 45 | 39 | 42.000 | 17.84 | 135.43% |
| 2023-06-06 | 3 | 45 | 32 | 38.666 | 15.26 | 153.38% |
| 2023-06-06 | 3 | 45 | 39 | 42.000 | 15.26 | 175.23% |
| 2023-06-06 | 2 | 45 | 32 | 38.666 | 15.26 | 153.38% |
| 2023-06-06 | 5 | 45 | 32 | 38.666 | 15.26 | 153.38% |
MLYS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
MLYS's average broker recommendation rating improved by 0 over the prior 31 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- MINERALYS THERAPEUTICS INC's number of analysts covering the stock is greater than 73.94% of all US stocks.
- MLYS has a greater upside potential (average analyst target price relative to current price) than 460.98% of all US stocks.
- In terms of how MINERALYS THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 40.95% of that group.
- MLYS has a higher average analyst price target than 424.6% of stocks in the small market cap category.
In the Pharmaceutical Products industry, CSBR, CDTX, and NAII are the three stocks most similar to MINERALYS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding MLYS using the data that counts. Try POWR Ratings for free.